A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins

作者：Riano Umbarila Lidia; Olamendi Portugal Timoteo; Morelos Juarez Citlalli; Gurrola Georgina B; Possani Lourival D; Becerril Baltazar^*

来源：Toxicon, 2013, 76: 370-376.

DOI：10.1016/j.toxicon.2013.09.016

• Human scFv
• In vitro maturation
• Scorpion toxin

Using phage display and directed evolution, our group has progressed in the construction of a second family of human single chain variable fragments (scFv) which bind to scorpion toxins dangerous to mammals. It was observed that scFv C1 only bound initially to toxin Cn2, which constitutes 6.8% of whole venom from the scorpion Centruroides noxius Hoffman. Only a few amino acid changes were necessary to extend its recognition to other similar toxins and without affecting the recognition for its primary antigen (Cn2 toxin). One variant of scFv C1 (scFv 202F) was selected after two cycles of directed evolution against CII1 toxin, the second major toxic component from the venom of the Mexican scorpion Centruroides limpidus limpidus Karsh (0.5% of the whole venom). scFv 202F is also capable of recognizing Cn2 toxin. Despite not having the highest affinity for toxins CII1 (K-D = 25.1 x 10(-9) M) or Cn2 (K-D = 8.1 x 10(-9) M), this antibody fragment neutralized one LD50 of each one of these toxins. Additionally, scFv 202F moderately recognized CII2 toxin which constitutes 1.5% of the venom from C limpidus. Based on our previous experience, we consider that these results are promising; consequently, we continue working on generating new optimized variants from scFv C1 that could be part of a recombinant scorpion anti-venom from human origin, that might reach the market in the near future.

• 出版日期2013-12-15